Novo Nordisk trumpets more Januvia-topping data for oral semaglutide
Just eight days after posting a trial win over Merck diabetes stalwart Januvia, Novo Nordisk candidate semaglutide is back with another....
FDA approves Epidiolex, the first marijuana-based pharmaceutical
On June 25th the FDA-approved Epidiolex (GW Pharmaceuticals plc), a cannabidiol (CBD) based drug to treat both Lennox-Gastaut and Dravet...
Aduro starts Phase 1b trial of its immunotherapy treatment for lung cancer
Immunotherapy company Aduro Biotech has announced it has initiated its Phase 1b study of its ADU-214 drug in combination with nivolumab...
